Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available. It may also be used in those with not enough of these factors due to other reasons such as warfarin therapy. It is given by slow injection into a vein. This report studies the global Prothrombin Complex Concentrate (PCC) Drug production, demand, key manufacturers, and key regions. This report is a detailed and comprehensive analysis of the world market for Prothrombin Complex Concentrate (PCC) Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Prothrombin Complex Concentrate (PCC) Drug that contribute to its increasing demand across many markets. The global Prothrombin Complex Concentrate (PCC) Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029). In Europe and United States market, key players of prothrombin complex concentrate (PCC) drug include CSL Behring, Grifols, Octapharma, Prothya Biosolutions, Takeda, etc. The top one player hold a share about 58%. United States is the largest market, has a share about 47%, followed by Germany, and France, with share 13% and 12%, separately. Highlights and key features of the study Global Prothrombin Complex Concentrate (PCC) Drug total production and demand, 2018-2029, (K Units) Global Prothrombin Complex Concentrate (PCC) Drug total production value, 2018-2029, (USD Million) Global Prothrombin Complex Concentrate (PCC) Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units) Global Prothrombin Complex Concentrate (PCC) Drug consumption by region & country, CAGR, 2018-2029 & (K Units) U.S. VS China: Prothrombin Complex Concentrate (PCC) Drug domestic production, consumption, key domestic manufacturers and share Global Prothrombin Complex Concentrate (PCC) Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units) Global Prothrombin Complex Concentrate (PCC) Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units) Global Prothrombin Complex Concentrate (PCC) Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units) This reports profiles key players in the global Prothrombin Complex Concentrate (PCC) Drug market based on the following parameters ﾖ company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL Behring, Grifols, Octapharma, Prothya Biosolutions and Takeda, etc. This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence. Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Prothrombin Complex Concentrate (PCC) Drug market Detailed Segmentation: Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year. Global Prothrombin Complex Concentrate (PCC) Drug Market, By Region: United States China Europe Japan South Korea ASEAN India Rest of World Global Prothrombin Complex Concentrate (PCC) Drug Market, Segmentation by Type Beriplex Profilnine Octaplex Prothromplex Cofact Other Global Prothrombin Complex Concentrate (PCC) Drug Market, Segmentation by Application Hemophilia B Acquired Coagulation Factor Deficiency Companies Profiled: CSL Behring Grifols Octapharma Prothya Biosolutions Takeda Key Questions Answered 1. How big is the global Prothrombin Complex Concentrate (PCC) Drug market? 2. What is the demand of the global Prothrombin Complex Concentrate (PCC) Drug market? 3. What is the year over year growth of the global Prothrombin Complex Concentrate (PCC) Drug market? 4. What is the production and production value of the global Prothrombin Complex Concentrate (PCC) Drug market? 5. Who are the key producers in the global Prothrombin Complex Concentrate (PCC) Drug market? 6. What are the growth factors driving the market demand?
1 Supply Summary 1.1 Prothrombin Complex Concentrate (PCC) Drug Introduction 1.2 World Prothrombin Complex Concentrate (PCC) Drug Supply & Forecast 1.2.1 World Prothrombin Complex Concentrate (PCC) Drug Production Value (2018 & 2022 & 2029) 1.2.2 World Prothrombin Complex Concentrate (PCC) Drug Production (2018-2029) 1.2.3 World Prothrombin Complex Concentrate (PCC)
